Forte Biosciences Ownership | Who Owns Forte Biosciences?
Forte Biosciences Ownership Summary
Forte Biosciences is owned by 41.38% institutional investors, 10.96% insiders, and 47.66% retail investors. Geode capital management is the largest institutional shareholder, holding 0.75% of FBRX shares. Alger Health Sciences A is the top mutual fund, with 3.27% of its assets in Forte Biosciences shares.
FBRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Forte Biosciences | 41.38% | 10.96% | 47.66% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Geode capital management | 346.29K | 0.75% | $186.01K |
Blackrock | 174.86K | 0.38% | $93.90K |
Two sigma investments, lp | 40.81K | 0.09% | $21.92K |
State street | 37.56K | 0.08% | $20.17K |
Susquehanna group, llp | 34.34K | 0.07% | $18.44K |
Ubs group | 24.31K | 0.05% | $13.05K |
Goldman sachs group | 20.78K | 0.05% | $11.16K |
Group one trading | 14.02K | 0.03% | $7.53K |
Morgan stanley | 3.80K | 0.01% | $2.04K |
Citadel advisors | 3.10K | 0.01% | $1.67K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Loring wolcott & coolidge fiduciary advisors llp/ma | - | - | - |
Renaissance | - | - | - |
Blackrock | 174.86K | - | $93.90K |
Two sigma advisers, lp | - | - | - |
Tower research capital llc (trc) | - | - | - |
Two sigma securities | - | - | - |
Bvf inc/il | - | - | - |
Susquehanna group, llp | 34.34K | - | $18.44K |
Advisor group | - | - | - |
Geode capital management | 346.29K | - | $186.01K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Susquehanna group, llp | 34.34K | - | 34.34K |
Ubs group | 24.31K | - | 24.28K |
Geode capital management | 346.29K | - | 2.86K |
Morgan stanley | 3.80K | - | 2.81K |
Citadel advisors | 3.10K | - | 2.10K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Tybourne capital management (hk) | - | - | -3.62M |
Perceptive advisors | - | - | -3.27M |
Bvf inc/il | - | - | -2.98M |
Cable car capital | - | - | -2.03M |
Fred alger management | - | - | -1.84M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Susquehanna group, llp | 34.34K | - | 34.34K | $18.44K |
Sold Out
Holder | Change |
---|---|
Qube research | -3.00 |
Fmr | -128.00 |
Loring wolcott & coolidge fiduciary advisors llp/ma | -193.00 |
Wells fargo & company/mn | -253.00 |
Advisor group | -1.08K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 33 | 3.13% | 19,068,395 | 0.10% | 41 | 1.14% | 10 | 42.86% | 6 | 20.00% |
Mar 31, 2024 | 32 | -8.57% | 19,048,537 | 0.98% | 60 | 2.43% | 7 | -30.00% | 5 | - |
Dec 31, 2023 | 35 | 9.38% | 18,863,225 | 12.96% | 49 | 0.79% | 10 | -28.57% | 5 | -28.57% |
Sep 30, 2023 | 32 | 3.23% | 16,699,693 | 381.91% | 79 | 29.16% | 14 | 27.27% | 7 | -12.50% |
Jun 30, 2023 | 31 | 3.33% | 3,465,339 | -10.35% | 16 | 4.87% | 11 | 37.50% | 8 | -11.11% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Alger Health Sciences A | 47.71K | 3.27% | -1.00 |
Alger LIfe Sciences Innovation Composite | 34.98K | 2.40% | 9.14K |
Vanguard Total Stock Mkt Idx Inv | 19.50K | 1.34% | - |
Fidelity Extended Market Index | 6.78K | 0.46% | -321.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 5.98K | 0.41% | - |
Fidelity Series Total Market Index | 1.58K | 0.11% | 1.05K |
BlackRock Extended Equity Market K | 1.09K | 0.07% | -1.00 |
Vanguard U.S. Eq Idx £ Acc | 918.00 | 0.06% | - |
Fidelity Total Market Index | 665.00 | 0.05% | - |
NT Ext Equity Mkt Idx Fd - L | 647.00 | 0.04% | -1.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 18, 2023 | Wagner Paul A. | See Remarks | Buy | $7.53K |
Dec 13, 2023 | Wagner Paul A. | See Remarks | Buy | $7.35K |
Dec 14, 2023 | Wagner Paul A. | See Remarks | Buy | $7.20K |
Dec 11, 2023 | Wagner Paul A. | See Remarks | Buy | $16.19K |
Dec 12, 2023 | Wagner Paul A. | See Remarks | Buy | $3.09K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | 11 | - |
FBRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools